Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Clover Announces Positive Preliminary Phase I Results for Bivalent RSV Vaccine Candidate SCB-1019 in Initial Young Adult Cohort 2024-04-08 17:19
Patient Enrolment Completed in CYP-006TK Diabetic Foot Ulcer Clinical Trial 2024-04-08 08:47
Innovent to Present Preclinical Data of Multiple Novel Molecules at the 2024 AACR Annual Meeting 2024-04-08 08:00
Antengene Presents Four Preclinical Posters at AACR 2024 2024-04-06 08:30
IRBM to Disclose Strong Antitumor Efficacy of Novel Preclinical Agents Against Aggressive Brain Tumors and Acute Lymphoblastic Leukemia at AACR 2024-04-04 21:00
Human Frontier Science Program: Fellowships Awarded to 59 of the Most Pioneering Postdoctoral Scientists from 28 Nations 2024-04-04 17:00
SOPHiA GENETICS and Strand Life Sciences Announce New Strategic Partnership 2024-04-04 13:00
YS Biopharma Announces Full Repayment of US$40,000,000 Loan Facility 2024-04-03 20:00
Tianlong Participated in International Medical Congress of SCO Countries in Kyrgyzstan 2024-04-03 16:16
Great Place To Work unveils Top 10 Best Workplaces in Singapore Healthcare and Biopharma™ 2024 2024-04-03 12:00
RemeGen's Telitacicept (RC18) Granted Fast Track Designation by United States FDA for Treatment of Primary Sjögren's Syndrome 2024-04-03 11:14
CONCEPT MEDICAL RECEIVES US FDA IDE APPROVAL FOR MAGICTOUCH AVF INDICATION, THEIR FIFTH US CLINICAL STUDY APPROVAL FOR THE MAGICTOUCH PORTFOLIO 2024-04-02 17:33
European Wellness Shines at AMWC 2024 in Monaco, with Prof. Dr Mike Chan and Prof. Dr Roni Moya as Faculty's Stem Cells Speakers 2024-04-02 14:16
Innovent and HUTCHMED Jointly Announce NDA Acceptance in China for Sintilimab Combination with Fruquintinib for the Treatment of Advanced Endometrial Cancer with Priority Review Status 2024-04-02 13:00
Fosun International: Total Revenue for 2023 Reached RMB198.2 billion, Industrial Operation Profit Increased by 20% YoY 2024-04-02 11:31
Kemwell BioPharma Drives Quality Excellence with Veeva Vault QMS 2024-04-02 10:30
Oncoclínicas&Co has revenues of R$6 billion and profit of R$313 million in 2023 2024-04-02 00:38
ThinkCyte advances biopharma phenotypic drug discovery programs with publication and presentation milestones 2024-04-01 21:00
Novel Immunogenicity Risk Assessment Platform, ISPRI, Facilitates Biologic Therapeutics Development 2024-04-01 20:00
Hyosung TNC Invests $1 Billion in Future "Bio" Business 2024-04-01 08:18
1 26 27 28 29 30 235